雷军投的机器人，要IPO了

Core Viewpoint - Beijing Shurui Robot Co., Ltd. is preparing for an IPO, having completed the IPO guidance filing with the Beijing Securities Regulatory Bureau, with CITIC Securities as the guiding institution [1][3]. Company Overview - Founded on November 5, 2014, by Professor Xu Kai from Shanghai Jiao Tong University, Shurui Robot focuses on the research, production, and commercialization of single-port minimally invasive surgical robot systems [2][5]. - Xu Kai directly holds 22.74% of the company's shares and controls an additional 31.84% through various partnerships, totaling 54.58% of voting rights [2][8]. Industry Context - The company is part of the domestic surgical robot sector, which has seen a wave of IPO attempts following the successful listing of MicroPort Robotics in 2021 [3][4]. - Shurui Robot is recognized as a leading startup in the surgical robot field, with Xu Kai having nearly 20 years of experience in this domain [5][6]. Technological Advancements - The company has developed a series of key technologies and core components, including a revolutionary design known as the "deformable dual-continuum mechanism," which enhances the performance of its surgical robots [6]. - Shurui Robot's single-port laparoscopic surgical robot became the first in China to pass the special review process for innovative medical devices in 2020 and received approval from the National Medical Products Administration (NMPA) in June 2023 [7]. Market Position and Financing - The company has completed six rounds of financing from 2019 to 2023, attracting notable venture capital firms such as Shunwei Capital and Medtronic [8]. - As of April 2025, Shurui Robot has filed over 805 patents globally, establishing a comprehensive intellectual property protection system [7].